Analyst Reco. Vanda Pharmaceuticals Inc.
Equities
VNDA
US9216591084
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.695 USD | -2.59% | -4.48% | +11.14% |
11-06 | Earnings Flash (VNDA) VANDA PHARMACEUTICALS Reports Q3 Revenue $47.7M | MT |
11-06 | Vanda Pharmaceuticals Inc., Q3 2024 Earnings Call, Nov 06, 2024 |
MarketScreener is also available in this country: United States.
Switch edition